Le Lézard
Classified in: Health, Science and technology, Covid-19 virus

Global Cell Free Protein Expression Market Trajectory & Analytics, 2022-2026: Rising Incidence of Cancer and the Demand for Biologics Spur the Adoption of Cell Free Protein Extraction - ResearchAndMarkets.com

The "Cell Free Protein Expression - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Cell Free Protein Expression Market to Reach $271.6 Million by 2026

Amid the COVID-19 crisis, the global market for Cell Free Protein Expression estimated at US$216.2 Million in the year 2022, is projected to reach a revised size of US$271.6 Million by 2026, growing at a CAGR of 5.7% over the analysis period.

Cell-free protein expression is ideal for experiments meant for characterizing protein-protein interactions and protein-nucleic acid interactions and for high-throughput and rapid expression of truncated or mutant proteins for the purpose of functional analysis. Another application for which the approach is considered ideal is mammalian protein expression with appropriate glycosylation and native PTMs (Post-translational Modifications).

The technique is also being increasingly used for stable isotopes containing proteins labeling, for the purpose of structural analysis and for the production of toxic polypeptides and functional virons. Researchers also use cell-free protein expression for analyzing components needed for protein stability, degradation and folding.

Protein-Protein Interaction, one of the segments analyzed in the report, is projected to grow at a 6.3% CAGR to reach US$147.9 Million by the end of the analysis period.

After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Protein Labeling segment is readjusted to a revised 4.8% CAGR for the next 7-year period. This segment currently accounts for a 24.1% share of the global Cell Free Protein Expression market.

The U.S. Market is Estimated at $110.3 Million in 2022, China is Forecast to Reach $25.7 Million by 2026

The Cell Free Protein Expression market in the U.S. is estimated at US$110.3 Million in the year 2022. The country currently accounts for a 51.51% share in the global market. China, the world's second largest economy, is forecast to reach an estimated market size of US$25.7 Million in the year 2026 trailing a CAGR of 7.5% through the analysis period.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR while Rest of European market (as defined in the study) will reach US$27.7 Million by the close of the analysis period.

Several pharmaceutical companies have in the recent years started research in the protein expression domain. Several biotech companies have also recently started initiatives which necessitate extensive use of cell-free protein expression, which is anticipated to provide the required impetus to market growth at the global level. The biological sector is also trying to use swifter and more agile protein synthesis methods further enhancing market growth dynamics.

Furthermore, technology advancements of over the years resulted in use of new expression elements like specially designed promoters exhibiting more efficient genomic engineering and translation leading to improved translation efficiency. There are also now software controlled algorithms facilitating better yield.

Other growth factors include increasing outsourcing of R&D by biotechnological and pharmaceutical companies, patent cliff sales reduction resulting in increased pharmaceutical sector research intensity, declining research productivity, and growing expenditure on development of biosimilars.

Advanced applications and increasing demand for more efficient and simpler methods for protein production also promote market growth. Different applications for cell-free protein expression include enzyme engineering, protein-protein interaction, protein purification and protein labeling, with the application of protein-protein interactions accounting for the largest percentage in overall market revenues at the global level owing to strong R&D initiatives for generation of protein libraries.

Enzyme Engineering Segment to Reach $41.7 Million by 2026

In the global Enzyme Engineering segment, USA, Canada, Japan, China and Europe will drive the 5.4% CAGR estimated for this segment.

These regional markets accounting for a combined market size of US$27 Million will reach a projected size of US$39 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3 Million by the year 2026.

What's New for 2022?

Key Topics Covered:




2. FOCUS ON SELECT PLAYERS (Total 34 Featured)





For more information about this report visit https://www.researchandmarkets.com/r/phk5m7

These press releases may also interest you

26 nov 2022
A study in the journal BMJ Global Health found that mothers who were exposed to a lot of digital marketing were less likely to breastfeed their babies for the first six months of their lives and more likely to give them processed foods and sugary...

25 nov 2022
Vaccine candidate has the potential to be the first available to help protect adults aged 60 years and older from lower respiratory tract disease caused by respiratory syncytial virusApplication includes important pivotal phase III data evaluating...

25 nov 2022
Summary Brand: LebbyProduct: Dark Chocolate Chickpea SnacksCompanies: Ecoideas Innovations Inc.Issue: Food ? Allergen ? MilkCategory: Candy, confectionary, snacks and sweetenersWhat to do: Do not consume recalled products to which you are allergic or...

25 nov 2022
It's easy to find personal training in New Braunfels, Texas, but it's difficult to find someone that's committed and focused on your goals. Health Yourzelf is the leader in personal training in the Comal County region. Led by Matt Zampas, he...

25 nov 2022
XORTX Therapeutics Inc. ("XORTX" or the "Company") , a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, has received notification from the Nasdaq Stock Market LLC Listing...

25 nov 2022
IMV Inc. ("IMV" or the "Company") , a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX® platform to treat solid and hematologic cancers, today announced that, on November 22, 2022, the Company...

News published on 6 october 2022 at 12:15 and distributed by: